Abstract
Dosage compensation, the mechanism by which organisms equalize the relative gene expression of dimorphic sex chromosomes, requires action of a diverse range of epigenetic mechanisms. The mammalian form, 'named X-chromosome inactivation' (XCI), involves silencing of one X chromosome in the female cell and regulation by genes that make noncoding RNAs (ncRNA). With large-scale genomic and transcriptome studies pointing to a crucial role for noncoding elements in organizing the epigenome, XCI emerges as a major paradigm and a focus of active research worldwide. With more surprising twists, recent advances point to the significance of RNA-directed chromatin change, chromosomal trans-interactions, nuclear organization, and evolutionary change. These findings have impacted our understanding of general gene regulation and are discussed herein.
| Original language | English |
|---|---|
| Pages (from-to) | 349-355 |
| Number of pages | 7 |
| Journal | Current Opinion in Cell Biology |
| Volume | 20 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jun 2008 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'New twists in X-chromosome inactivation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver